Sofinnova Investments, Inc. Uni Qure N.V. Transaction History

Sofinnova Investments, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$14.54 - $21.5 $7.2 Million - $10.6 Million	-495,025 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$20.24 - $36.01 $8.43 Million - $15 Million	416,283 Added 528.67%	495,025 $10.3 Million
Q3 2021 Nov 15, 2021	SELL	$26.01 - $38.22 $6.39 Million - $9.39 Million	-245,561 Reduced 75.72%	78,742 $2.52 Million
Q2 2021 Aug 16, 2021	SELL	$29.97 - $37.17 $3.08 Million - $3.82 Million	-102,819 Reduced 24.07%	324,303 $9.99 Million
Q1 2021 May 14, 2021	BUY	$29.24 - $42.03 $12.5 Million - $18 Million	427,122 New	427,122 $14.4 Million

142

35.3M

1.54M

389K

Ticker QURE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,729,100
Market Cap $300M
Description
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...

Get notified when there are updates to the investment portfolio of Sofinnova Investments, Inc., based on Form 13F filings with the SEC.

Stay updated on Sofinnova Investments, Inc. with notifications on news.